Market Overview

The Global Bioanalytical Testing Services Market was valued at USD 3,610.8 million in 2023 and is expected to reach USD 12,002.0 million by 2031 while growing at a CAGR of 16.2% during the forecast period (2024-2031).

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Market Dynamics

This section of the report will analyze various driving and restraining factors that are expected to have a significant impact on the global bioanalytical testing services market growth. Bioanalytical testing services involve laboratory procedures to detect and quantify specific molecules in biological samples, crucial in pharmaceuticals, biotechnology, healthcare, and environmental science. Techniques like chromatography, mass spectrometry, immunoassays, and molecular biology assess safety, efficacy, and quality of pharmaceuticals and aid in understanding biological processes and disease mechanisms.

Increasing drug development activities, coupled with continuous advancements in analytical technologies like chromatography, mass spectrometry, and immunoassays, drive the bioanalytical testing services market. However, the high cost of services and ethical and legal concerns serve as hindrances to its growth.

Furthermore, the global bioanalytical testing services industry will be analyzed through various tools including PESTLE analysis, and Porter’s analysis.

Segmentation – By Type Analysis

The Global Bioanalytical Testing Services Market is segmented among Cell-based Assays, Bacterial cell-based assays, Viral cell-based assays, Virology Testing, In Vitro Virology Testing, Species-specific Viral PCR Assays, Biomarker Testing, Pharmacokinetic Testing, and Other Services, based on Type. In 2023, Cell-based Assays accounted for the majority of the market share*.

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Segmentation – By Application Analysis

The Global Bioanalytical Testing Services Market is segmented among Oncology, Neurology, Infectious Diseases, Gastroenterology, Cardiology, and Other Applications, based on Application. In 2023, Oncology accounted for the majority of the market share*.

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Global Bioanalytical Testing Services Market: Regional Analysis

Based on region, the market is divided into six regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. In 2023, North America dominated the market with the highest market share, while Asia Pacific is expected to grow with the highest CAGR during the forecast period (2024 – 2031).

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Competitive Landscape

Some of the key players operating in the market are Thermo Fisher Scientific Inc (PPD, Inc.), ICON Plc, Charles River Laboratories International, Covance, Inc., IQVIA, Syneos Health, SGS SA, Labcorp (Toxikon), Intertek Group Plc, and Pace Analytical Services LLC.

Table of Contents:

1. Research Methodology and Market Scope

• Research Methodology

• Market Scope

2. Executive Summary

3. Global Bioanalytical Testing Services Market Dynamics

• Drivers

• Restraints

• Opportunity

4. Global Bioanalytical Testing Services Industry Analysis

• PEST Analysis

• Porter's Five Force Analysis

• Recent Deals Analysis

5. Global Bioanalytical Testing Services Market Segmentation, By Type

• Global Bioanalytical Testing Services Market Share Analysis, By Type

• Global Bioanalytical Testing Services Market Growth Analysis, By Type

• Global Bioanalytical Testing Services Market Trends, By Type

o Cell-based Assays

o Bacterial cell-based assays

o Viral cell-based assays

o Virology Testing

o In Vitro Virology Testing

o Species-specific Viral PCR Assays

o Biomarker Testing

o Pharmacokinetic Testing

o Other Services

6. Global Bioanalytical Testing Services Market Segmentation, By Application

• Global Bioanalytical Testing Services Market Share Analysis, By Application

• Global Bioanalytical Testing Services Market Growth Analysis, By Application

• Global Bioanalytical Testing Services Market Trends, By Application

o Oncology

o Neurology

o Infectious Diseases

o Gastroenterology

o Cardiology

o Other Applications

7. Global Bioanalytical Testing Services Market Segmentation, By End User

• Global Bioanalytical Testing Services Market Share Analysis, By End User

• Global Bioanalytical Testing Services Market Growth Analysis, By End User

• Global Bioanalytical Testing Services Market Trends, By End User

o Pharmaceutical and Biopharmaceutical Companies

o Contract Development and Manufacturing Organizations

o Contract Research Organizations

8. Global Bioanalytical Testing Services Market Segmentation, By Region

• Global Bioanalytical Testing Services Market Share Analysis, By Region

• Global Bioanalytical Testing Services Market Growth Analysis, By Region

• Global Bioanalytical Testing Services Market Trends, By Region

o North America

o Europe

o Asia Pacific

o Latin America

o Middle East

o Africa

9. Competitive Landscape

• Thermo Fisher Scientific Inc (PPD, Inc.)*

o Company Overview

o Financial Performance

o Key Development/Strategies

o SWOT Analysis

• ICON Plc

• Charles River Laboratories International

• Covance, Inc.

• IQVIA

• Syneos Health

• SGS SA

• Labcorp (Toxikon)

• Intertek Group Plc

• Pace Analytical Services LLC

*Similar analysis will be provided for each company listed above.